| Teva Pharma AG - Fulvestrant-Teva 250mg/5ml, Injektionslösung in einer Fertigspritze |
| 66470 | | 01 | | Fulvestrant-Teva 250mg/5ml | | Injektionslösung in einer Fertigspritze | | L02BA03 | | Fulvestrant | | 27.07.2017 | | |
|
| Composition |
| fulvestrantum 250 mg, ethanolum 96 per centum 500 mg, alcohol benzylicus 500 mg, benzylis benzoas 750 mg, ricini oleum raffinatum q.s. ad solutionem pro 5 ml corresp. ethanolum 12.16 % V/V. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Fulvestrant | 250mg / 5ml |
| | BAG: Active Agent | Dose |
|---|
| Fulvestrant | 250 mg |
| | | | Inactive agents | Dose |
|---|
| Alcohol Benzylicus | 500mg / 5ml | | Benzyl Benzoate | 750mg / 5ml | | Ethanolum 96 Per Centum | 500mg / 5ml | | Ricini Oleum Raffinate | |
| |
|
|
